IL-35
Interleukin-35 is a glycosylated, heterodimeric protein consisting of the p35 subunit from IL-12 (IL-12α) and the β subunit from IL-27 (EBI3) . IL-35 can be expressed by regulatory T-cells (Tregs), macrophages, and certain trophoblast and dendritic cells. It is induced in response to inflammation, and generally acts as an inflammation suppressor. IL-35 suppresses inflammation by exerting multiple activities, including the induction of regulatory T-cells and the suppression of Th17 cells. Recombinant Human IL-35 produced from HEK293 cells is a glycosylated protein, primarily heterodimeric, that migrates as a diffuse band centered at an apparent molecular weight of about 60 kDa by SDS-PAGE analysis under non-reducing conditions. Recombinant Human IL-35 expressed in HEK293 cells contains 406 amino acid residues and has a calculated molecular weight of 45.8 kDa.
Product Specifications
Synonyms
Interleukin-35
NCBI Gene ID
Alpha: 3592 Beta: 10148
UniProt
Alpha: P29459 Beta: Q14213
Accession Number
Alpha: NP_001384921 Beta: NP_005746
Accession Number mRNA
Alpha: NM_001397992 Beta: NM_005755
Reactivity
Human
Cross Reactivity
Human, Mouse
Sequence
Endotoxin
< 0.1 ng/µg of protein (< 1EU/µg)
Purity
≥ 90% by SDS-PAGE gel and HPLC analyses.
Bioactivity
Measured by its ability to inhibit proliferative activity of PBMCs.
Length
406
Form
Lyophilized
Molecular Weight
45.8 kDa
Host or Source
HEK 293 cells
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items